Plunkett Research Online: Nymox Pharmaceutical Corporation

NYMOX PHARMACEUTICAL CORPORATION (NYMX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. It markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. It opera.....


NYMOX PHARMACEUTICAL CORPORATION

Ticker: NYMX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 800 936-9669
Fax: 514 332-2227
Address: 9900, boul. Cavendish, Bureau 306
St. Laurent, QC H4M 2V2 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Paul AverbackCEO/Chairman of the Board/Director/Founder/President
Erik DanielsenCFO
See More
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. It markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. It opera.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture